Status:
WITHDRAWN
Drugmonitoring of Antiinfective Drugs in Patients Receiving Continous Veno-venous Hemodiafiltration (ABx-CVVHDF)
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Need for Renal Replacement Therapy and Anti-infective Therapy Due to Severe Infection
Eligibility:
All Genders
18+ years
Brief Summary
Approximately 300 patients have to be enrolled in the study. They are followed up until the end of ICU stay. Usually in clinical routine, patients suspected to have infection and simultaneously renal ...
Detailed Description
Little data exist whether desired and necessary blood levels of antiinfective drugs are reached during renal replacement therapy. Drug producing companies are not able to come forward with appropriate...
Eligibility Criteria
Inclusion
- Male and female patients, age ≥ 18 years
- Patients in the intensive care unit (ICU), needing renal replacement therapy due to renal dysfunction and are treated with antiinfective drugs
Exclusion
- Pregnancy and lactation period.
- Participation in a clinical intervention study
- Lacking willingness to save and hand out data within the study
- Accommodation in an institution due to an official or judicial order
- The informed consent of the patient or the subject's legally acceptable representative can´t be obtained in time
- Patient has a power of attorney or patient's provision, where he/she refuses participation in any clinical trial
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2016
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02242721
Start Date
October 1 2014
End Date
January 1 2016
Last Update
July 31 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Pharmacy, Kliniken Landkreis Heidenheim gGmbH
Heidenheim, Heidenheim, Germany, 89522
2
Medical Department, Division of Nephrology, Campus Charité Mitte, Charité - Universitätsmedizin Berlin
Berlin, State of Berlin, Germany, 10117